Kura Oncology Stock Technical Analysis

KURA
 Stock
  

USD 14.98  0.28  1.90%   

As of the 29th of November, Kura Oncology secures the Risk Adjusted Performance of 0.0179, mean deviation of 2.85, and Downside Deviation of 3.42. Kura Oncology technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Kura Oncology, which can be compared to its peers in the industry. Please verify Kura Oncology variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and semi variance to decide if Kura Oncology is priced some-what accurately, providing market reflects its recent price of 14.98 per share. Given that Kura Oncology has jensen alpha of (0.003505), we recommend you to check Kura Oncology's last-minute market performance to make sure the company can sustain itself at a future point.
  

Kura Oncology Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Kura Oncology, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Kura Oncology
Kura Oncology's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Kura Oncology Analyst Consensus

Target PriceAdvice# of Analysts
42.25Strong Buy4Odds
Kura Oncology current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Kura Oncology analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Kura Oncology stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Kura Oncology, talking to its executives and customers, or listening to Kura Oncology conference calls.
Kura Oncology Analyst Advice Details
Kura Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Kura Oncology technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Kura Oncology trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Kura Oncology Technical Analysis

Indicator
The output start index for this execution was one with a total number of output elements of sixty. The True Range is a measure of Kura Oncology volatility developed by Welles Wilder.
.

Kura Oncology Trend Analysis

Use this graph to draw trend lines for Kura Oncology. You can use it to identify possible trend reversals for Kura Oncology as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Kura Oncology price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Kura Oncology Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Kura Oncology applied against its price change over selected period. The best fit line has a slop of   0.028274  , which means Kura Oncology will continue generating value for investors. It has 122 observation points and a regression sum of squares at 30.23, which is the sum of squared deviations for the predicted Kura Oncology price change compared to its average price change.

About Kura Oncology Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Kura Oncology on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Kura Oncology based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Kura Oncology price pattern first instead of the macroeconomic environment surrounding Kura Oncology. By analyzing Kura Oncology's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Kura Oncology's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Kura Oncology specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2019 2020 2021 2022 (projected)
Current Ratio15.3924.4923.2625.09
Book Value per Share5.2211.517.647.63

Kura Oncology November 29, 2022 Technical Indicators

Most technical analysis of Kura Oncology help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Kura Oncology from various momentum indicators to cycle indicators. When you analyze Kura Oncology charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Kura Oncology November 29, 2022 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Kura Oncology stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Please see Correlation Analysis. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for analysis

When running Kura Oncology price analysis, check to measure Kura Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kura Oncology is operating at the current time. Most of Kura Oncology's value examination focuses on studying past and present price action to predict the probability of Kura Oncology's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kura Oncology's price. Additionally, you may evaluate how the addition of Kura Oncology to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Is Kura Oncology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kura Oncology. If investors know Kura Oncology will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kura Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
998.8 M
Return On Assets
(0.17) 
Return On Equity
(0.28) 
The market value of Kura Oncology is measured differently than its book value, which is the value of Kura Oncology that is recorded on the company's balance sheet. Investors also form their own opinion of Kura Oncology's value that differs from its market value or its book value, called intrinsic value, which is Kura Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kura Oncology's market value can be influenced by many factors that don't directly affect Kura Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kura Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine Kura Oncology value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kura Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.